课题基金 / 基金详情

Molecular Mechanisms of Myoblast Fusion

Molecular Mechanisms of Myoblast Fusion
成肌细胞融合的分子机制
批准号:
9450282
负责人:
Elizabeth H Chen
金额:
$7.98万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-15 至 2018-03-31

项目摘要

项目成果

Elizabeth H Chen的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):骨骼肌是由多核肌纤维组成的独特器官,每条肌纤维都是数百甚至数千个成肌细胞融合的产物。成肌细胞融合不仅对骨骼肌的发育很重要,而且对基于卫星细胞的肌肉再生也至关重要。尽管几十年来进行了大量的研究,但人类成肌细胞融合的机制仍然知之甚少。最近对果蝇的研究已经开始揭示成肌细胞融合的分子和细胞机制的前所未有的细节。果蝇和哺乳动物之间惊人的进化守恒使得果蝇成为研究体内成肌细胞融合的一个特别相关的系统。我们实验室最近的研究揭示了成肌细胞融合的一种新的细胞机制。我们发现成肌细胞融合是由一种细胞类型特异性的、富含f -肌动蛋白的足囊体样结构(PLS)介导的,该结构通过多个突出的手指侵入对立的融合伙伴,导致融合孔的形成。为了进一步表征介导成肌细胞融合的关键细胞结构侵袭性PLS的调控,我们建议研究两个新基因DPak3和dynamin的分子和细胞功能,这两个基因之前都与人类疾病有关。我们将采用多方面的方法,包括遗传学、细胞生物学和生物化学,来研究DPak3和动力蛋白在果蝇成肌细胞融合中调节肌动蛋白聚合动力学的机制。我们还将研究它们的哺乳动物同源物在小鼠C2C12成肌细胞融合中的功能。考虑到苍蝇和哺乳动物之间成肌细胞融合的分子和细胞保守性,使用更简单和遗传可处理的果蝇系统进行的机制研究将导致对人类肌肉生物学在健康和疾病方面的重要见解,并最终为开发更有效的治疗生命衰弱性肌肉退行性疾病提供基础。
英文摘要
DESCRIPTION (provided by applicant): Skeletal muscle is a unique organ that is composed of multinucleate muscle fibers, each of which is the product of fusion of hundreds or even thousands of myoblasts. Myoblast fusion is not only important for skeletal muscle development, but also critical for satellite cell-based muscle regeneration. Despite a large body of studies ove several decades, the mechanisms underlying myoblast fusion in humans remain poorly understood. Recent studies in the fruit fly Drosophila have begun to reveal unprecedented details about the molecular and cellular mechanisms of myoblast fusion. The striking evolutionary conservation between fly and mammalian myogenesis makes Drosophila a particularly relevant system to study myoblast fusion in vivo. Recent studies from our lab have uncovered a novel cellular mechanism underlying myoblast fusion. We show that myoblast fusion is mediated by a cell type-specific, F-actin-enriched podosome-like structure (PLS), which invades the opposing fusion partner with multiple protrusive fingers leading to fusion pore formation. To further characterize the regulation of the invasive PLS, the key cellular structure mediating myoblast fusion, we propose to investigate the molecular and cellular functions of two new genes, DPak3 and dynamin, both have previously been implicated in human diseases. We will use a multifaceted approach, including genetics, cell biology and biochemistry, to study the mechanisms by which DPak3 and dynamin regulate actin polymerization dynamics within the PLS in Drosophila myoblast fusion. We will also investigate the function of their mammalian orthologs in the fusion of mouse C2C12 myoblasts. Given the molecular and cellular conservation of myoblast fusion between fly and mammals, the proposed mechanistic studies using the simpler and genetically tractable Drosophila system will lead to significant insights int human muscle biology in health and disease, and ultimately provide a basis for developing more efficient therapeutics against the life debilitating muscle degeneration diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms of Myoblast Fusion
  • 批准号:
    10928438
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2023
  • 负责人:
    Elizabeth H Chen
  • 依托单位:
Skeletal Muscle: Development, Regeneration and Disease
  • 批准号:
    10237575
  • 项目类别:
  • 资助金额:
    $2.0万
  • 财政年份:
    2021
  • 负责人:
    Elizabeth H Chen
  • 依托单位:
Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model
  • 批准号:
    10213657
  • 项目类别:
  • 资助金额:
    $34.98万
  • 财政年份:
    2020
  • 负责人:
    Elizabeth H Chen
  • 依托单位:
Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model
  • 批准号:
    10408109
  • 项目类别:
  • 资助金额:
    $35.72万
  • 财政年份:
    2020
  • 负责人:
    Elizabeth H Chen
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位: